Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | PLA2G4B | P0C869 | 7/20 | 0.54 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | RARB | P10826 | 5/20 | 0.51 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8434202 | 1.00 | KMT2A (0.59) | KMT2ATP53TSHRPLA2G4BGPR88 | |
| SCHEMBL8072342 | 0.95 | TP53 (0.58) | KMT2ATP53TSHRPLA2G4BGPR88 | |
| SCHEMBL8436176 | 0.95 | TP53 (0.58) | KMT2ATP53TSHRPLA2G4BGPR88 | |
| SCHEMBL5091731 | 0.94 | TP53 (0.60) | KMT2ATP53TSHRPLA2G4BMAPK1 | |
| SCHEMBL4602775 | 0.94 | TP53 (0.60) | KMT2ATP53TSHRPLA2G4BMAPK1 | |
| SCHEMBL8081206 | 0.94 | TP53 (0.60) | KMT2ATP53TSHRPLA2G4BMAPK1 | |
| SCHEMBL13953004 | 0.94 | TP53 (0.60) | KMT2ATP53TSHRPLA2G4BMAPK1 | |
| SCHEMBL25788012 | 0.94 | TP53 (0.60) | KMT2ATP53TSHRPLA2G4BMAPK1 | |
| SCHEMBL7691425 | 0.94 | TP53 (0.60) | KMT2ATP53TSHRPLA2G4BMAPK1 | |
| SCHEMBL9058650 | 0.94 | TP53 (0.60) | KMT2ATP53TSHRPLA2G4BMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2958950-B1 | AN IMPROVED MAGNESIUM DICHLORIDE SUPPORTED TITANIUM CATALYST COMPOSITION FOR POLYOLEFIN POLYMERIZATION | RELIANCE INDUSTRIES LTD (IN) | 2019-09-11 | — | — | EP | claimed |
| US-20160002372-A1 | Magnesium Dichloride Supported Titanium Catalyst Composition for Polyolefin Polymerization | RELIANCE INDUSTRIES LIMITED (IN) | 2016-01-07 | — | — | US | claimed |
| EP-2958950-A2 | AN IMPROVED MAGNESIUM DICHLORIDE SUPPORTED TITANIUM CATALYST COMPOSITION FOR POLYOLEFIN POLYMERIZATION | Reliance Industries Limited (IN) | 2015-12-30 | — | — | EP | claimed |
| WO-2014128715-A2 | AN IMPROVED MAGNESIUM DICHLORIDE SUPPORTED TITANIUM CATALYST COMPOSITION FOR POLYOLEFIN POLYMERIZATION | RELIANCE INDUSTRIES LIMITED (IN) | 2014-08-28 | — | — | WO | claimed |
| EP-2958950-B1 | AN IMPROVED MAGNESIUM DICHLORIDE SUPPORTED TITANIUM CATALYST COMPOSITION FOR POLYOLEFIN POLYMERIZATION | RELIANCE INDUSTRIES LTD (IN) | 2019-09-11 | — | — | EP | disclosed |
| US-20160002372-A1 | Magnesium Dichloride Supported Titanium Catalyst Composition for Polyolefin Polymerization | RELIANCE INDUSTRIES LIMITED (IN) | 2016-01-07 | — | — | US | disclosed |
| EP-2958950-A2 | AN IMPROVED MAGNESIUM DICHLORIDE SUPPORTED TITANIUM CATALYST COMPOSITION FOR POLYOLEFIN POLYMERIZATION | Reliance Industries Limited (IN) | 2015-12-30 | — | — | EP | disclosed |
| WO-2014128715-A2 | AN IMPROVED MAGNESIUM DICHLORIDE SUPPORTED TITANIUM CATALYST COMPOSITION FOR POLYOLEFIN POLYMERIZATION | RELIANCE INDUSTRIES LIMITED (IN) | 2014-08-28 | — | — | WO | disclosed |
| EP-1846366-B1 | NORVALINE DERIVATIVE AND METHOD FOR PREPARATION THEREOF | MITSUBISHI TANABE PHARMA CORP (JP) | 2011-08-03 | — | — | EP | disclosed |
| US-7718703-B2 | Norvaline derivative and method for preparation thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-05-18 | — | — | US | disclosed |
| US-7718703-B2 | Norvaline derivative and method for preparation thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-05-18 | — | — | US | disclosed |
| US-20080076769-A1 | Norvaline Derivative and Method for Preparation Thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20080076769-A1 | Norvaline Derivative and Method for Preparation Thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| EP-0758013-B1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL CO LTD (JP) | 2000-10-11 | — | — | EP | disclosed |
| US-5855971-A | Liquid crystalline optical film, compensating film for liquid crystal display comprising the liquid crystalline optical film, and liquid crystal display having the compensating film | NIPPON OIL COMPANY, LIMITED (JP) | 1999-01-05 | — | — | US | disclosed |
| EP-0758013-A1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL COMPANY, LIMITED (JP) | 1997-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076769-A1 | Norvaline Derivative and Method for Preparation Thereof | SLC38A7, SLC7A1, SLC6A7 | KMT2A 2225/4885TP53 4367/4885TSHR 1786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.